Urinary D-asparagine level is decreased by the presence of glioblastoma-Reference-Cited by-同舟云学术

Urinary D-asparagine level is decreased by the presence of glioblastoma

Published:2024-08-20 Issue:1 Volume:12 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Nakade Yusuke,Kinoshita Masashi,Nakada Mitsutoshi^ORCID,Sabit Hemragul,Ichinose Toshiya,Mita Masashi,Yuno Takeo,Noguchi-Shinohara Moeko,Ono Kenjiro,Iwata Yasunori,Wada Takashi

Funder

JSPS KAKENHI

Hokkoku Cancer Foundation

Kanazawa University JIKO-CHOKOKU project

Kanazawa University Hospital SAKIGAKE

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s40478-024-01836-6.pdf

Reference36 articles.

1. DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, Wu D et al (2015) NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet 47:1475–1481. https://doi.org/10.1038/ng.3421

2. Dong Y, Furuta T, Sabit H, Kitabayashi T, Jiapaer S, Kobayashi M et al (2017) Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug. Oncotarget 8:111728–111741. https://doi.org/10.18632/oncotarget.22904

3. Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J et al (2018) In vivo PET assay of tumor glutamine flux and metabolism: In-human trial of 18F-(2S,4R)-4-fluoroglutamine. Radiology 287:667–675. https://doi.org/10.1148/radiol.2017162610

4. El Sayed SM, Abou El-Magd RM, Shishido Y, Chung SP, Sakai T, Watanabe H et al (2012) D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate. Cancer Gene Ther 19:1–18. https://doi.org/10.1038/cgt.2011.59

5. Firdous S, Abid R, Nawaz Z, Bukhari F, Anwer A, Cheng LL et al (2021) Dysregulated alanine as a potential predictive marker of glioma-an insight from untargeted HRMAS-NMR and machine learning data. Metabolites 11:507. https://doi.org/10.3390/metabo11080507